Dynamic M&A Intelligence built for Medtech Companies

Establish market reality, quantify acquisition exposure, and convert objection risk into defensible negotiation leverage.

Industry Insights

Market-wide acquisition intelligence with hyper-filterable dashboards and deal-level data. Analyze trends across the full life sciences M&A landscape—from deal size and timing to buyer behavior and market momentum.

Deal Size vs Stage Benchmarks

See where value actually clears by stage with distributions, medians, and quartiles across comparable transactions.

Premium Survival Conditions

Identify where premiums survive (and where they compress) across sector, stage, and product type using historical clearing behavior.

Buyer Intolerance Signals

Spot patterns where buyers show low tolerance—deal structures, stages, or categories where outcomes consistently compress.

Advanced Transaction Database

Hyper-filter transactions across buyers, timing, structure, sector, stage, and rationale to ground every narrative in reality.

Rationale Pattern Heatmaps

Map where deals cluster by stage and rationale to uncover repeatable patterns in strategic intent and acquisition behavior.

Repeat Acquirer Behavior

Understand who buys, how often, at what stages, and in which segments—so “buyer strategy” is based on actions, not guesses.

User Insights

Profile-driven acquisition readiness assessment with real-time scoring, valuation benchmarking, top acquirer identification, and exit timing signals based on similar companies’ exit paths. Intelligence tailored to your company.

Acquisition Readiness Score

Real-time composite score based on your company profile and market signals. Track readiness over time and understand key drivers.

Top Potential Acquirers

Ranked list of acquirers most active in buying companies like yours, scored by strategic fit and recent deal activity.

Valuation Range Benchmarking

Median, top quartile, and bottom quartile exit values from comparable acquisitions. Validate your target valuation against market reality.

Similar Companies Analysis

Proximity-scored table of comparable exits with full deal details. Export to CSV for your own deeper analysis.

Historical Exit Timelines

Stage-specific exit timing visualizations showing valuation ranges and deal windows. Understand when similar companies typically get acquired.

Market Momentum Indicators

Year-over-year acquisition growth in your sector and stage, with signals on market momentum, readiness, and timing.

Acquisition Defense

Convert exposure into leverage. Quantify premium defense difficulty, surface top buyer objections, and build an evidence-backed defense plan—before diligence turns fragility into pricing leverage.

Premium Defense Difficulty Score

Quantify how difficult it will be to defend your valuation premium based on historical outcomes and buyer behavior.

Vulnerability Exposure

Surface your top buyer objections ranked by severity so you can address the highest-leverage risks first.

Defense Evidence Stack

Build an evidence-backed defense plan tied to market reality—what’s provable, what’s fragile, and what needs reinforcement.

Acquirer-Specific Attack Surfaces

Identify where each likely buyer will push hardest so you can pre-wire defenses before process conversations.

Negotiation Leverage Signals

Translate exposure into leverage signals—where you’re structurally strong, what you’ll anchor on, and what changes move the needle.

Defense Playbook Builder

Convert insights into a step-by-step negotiation plan—what to anchor on, where buyers will push, and how to defend price throughout diligence.

See Inflexion in action

Get started today and access comprehensive M&A intelligence for the medical device and life sciences sector.